Market Cap 113.10M
Revenue (ttm) 1.00M
Net Income (ttm) -130.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13,093.00%
Debt to Equity Ratio 0.00
Volume 323,200
Avg Vol 343,876
Day's Range N/A - N/A
Shares Out 20.98M
Stochastic %K 84%
Beta 0.98
Analysts Strong Sell
Price Target $19.50

Company Profile

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec Ixo-vec, a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials. The company is developing BGTF-027 (AAV.7m8-L-opsin), a novel gene therapy product candidate designed to deliver a f...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 656 9323
Fax: 650 649 1995
Website: adverum.com
Address:
100 Cardinal Way, Redwood City, United States
ATerragna
ATerragna Oct. 3 at 7:41 PM
$ADVM Cup and handle on the YTD
0 · Reply
DEADSTOCKSTRADER
DEADSTOCKSTRADER Oct. 2 at 7:46 PM
0 · Reply
Todrea92
Todrea92 Oct. 2 at 1:40 PM
0 · Reply
HOSTILE
HOSTILE Oct. 1 at 5:57 PM
$ADVM 👀 @RonIsWrong are you still keeping up with this?
1 · Reply
highnihilism
highnihilism Oct. 1 at 9:32 AM
$EQ Equillium Trade Count: 13 | Total $: 3.1 K | 0.17 × 90-Day Avg $: 18.2 K | Call $: 3.1 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $ADVM Adverum Biotechnologies Trade Count: 17 | Total $: 9.4 K | 1.41 × 90-Day Avg $: 6.7 K | Call $: 3.1 K | Put $: 6.3 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $GDE WisdomTree Efficient Gold Plus Equity Strategy Trade Count: 6 | Total $: 5 K | 0.97 × 90-Day Avg $: 5.2 K | Call $: 3.1 K | Put $: 1.9 K | % Single-Leg: 74% | % Multi-Leg: 26% | % Contingent: – $AVY Avery Dennison Trade Count: 4 | Total $: 3.1 K | 0.17 × 90-Day Avg $: 18.2 K | Call $: 3.1 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
ATerragna
ATerragna Sep. 29 at 2:20 PM
$ADVM $5 calls print this week
0 · Reply
IIStock_LesnarII
IIStock_LesnarII Sep. 26 at 3:43 PM
$ADVM $NUAI $BIAF $DVLT I have already traded or am still trading all of these today. Great options for a slower Friday. “It’s a great day to body slam the competition— and leg drop em’”
0 · Reply
ATerragna
ATerragna Sep. 26 at 3:29 PM
$ADVM $4C - $5C printing hard
0 · Reply
DEADSTOCKSTRADER
DEADSTOCKSTRADER Sep. 26 at 5:46 AM
0 · Reply
twin_dad
twin_dad Sep. 25 at 9:37 PM
$ADVM $23 BO this year.
2 · Reply
Latest News on ADVM
ATerragna
ATerragna Oct. 3 at 7:41 PM
$ADVM Cup and handle on the YTD
0 · Reply
DEADSTOCKSTRADER
DEADSTOCKSTRADER Oct. 2 at 7:46 PM
0 · Reply
Todrea92
Todrea92 Oct. 2 at 1:40 PM
0 · Reply
HOSTILE
HOSTILE Oct. 1 at 5:57 PM
$ADVM 👀 @RonIsWrong are you still keeping up with this?
1 · Reply
highnihilism
highnihilism Oct. 1 at 9:32 AM
$EQ Equillium Trade Count: 13 | Total $: 3.1 K | 0.17 × 90-Day Avg $: 18.2 K | Call $: 3.1 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $ADVM Adverum Biotechnologies Trade Count: 17 | Total $: 9.4 K | 1.41 × 90-Day Avg $: 6.7 K | Call $: 3.1 K | Put $: 6.3 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $GDE WisdomTree Efficient Gold Plus Equity Strategy Trade Count: 6 | Total $: 5 K | 0.97 × 90-Day Avg $: 5.2 K | Call $: 3.1 K | Put $: 1.9 K | % Single-Leg: 74% | % Multi-Leg: 26% | % Contingent: – $AVY Avery Dennison Trade Count: 4 | Total $: 3.1 K | 0.17 × 90-Day Avg $: 18.2 K | Call $: 3.1 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
ATerragna
ATerragna Sep. 29 at 2:20 PM
$ADVM $5 calls print this week
0 · Reply
IIStock_LesnarII
IIStock_LesnarII Sep. 26 at 3:43 PM
$ADVM $NUAI $BIAF $DVLT I have already traded or am still trading all of these today. Great options for a slower Friday. “It’s a great day to body slam the competition— and leg drop em’”
0 · Reply
ATerragna
ATerragna Sep. 26 at 3:29 PM
$ADVM $4C - $5C printing hard
0 · Reply
DEADSTOCKSTRADER
DEADSTOCKSTRADER Sep. 26 at 5:46 AM
0 · Reply
twin_dad
twin_dad Sep. 25 at 9:37 PM
$ADVM $23 BO this year.
2 · Reply
highnihilism
highnihilism Sep. 25 at 12:36 PM
Volume (Relative to 90-Day Average) → $ADVM Adverum Biotechnologies × 2.7 $MDXH MdXHealth × 1.7 $IONR Ioneer × 12.8 $RICH Rchtech Robotics × 2.4 $TROX Tronox × 1.8
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Sep. 25 at 1:23 AM
$ADVM $FDMT FDMT is both FIC and BIC. There's a reason for the run into data.
0 · Reply
SecondChances
SecondChances Sep. 24 at 6:58 PM
$ADVM $FDMT Race is on between these 2 to be the first to complete phase 3. Advm seems to have edge in trial1 where as fdmt seems ahead to complete trial2. Can both be winners?
2 · Reply
IIStock_LesnarII
IIStock_LesnarII Sep. 24 at 2:16 PM
$ADVM $QURE $LAC $ATCH $XRP.X These are my slammers. ADVM is my new superstar. Higher Highs and Higher lows in the last couple of months. I see this going to previous highs earlier this year. This can 2x or 3x in the near future. This stock is undervalued. 💎💎💎 “Eat. Sleep. Conquer. Repeat.”
1 · Reply
highnihilism
highnihilism Sep. 24 at 1:23 PM
Market cap ≤ $500M (Unusual Volume, Biotech) $ADVM Adverum Biotechnologies $ANIX Anixa Biosciences $BNOX Bionomics $CANF Can-Fite BioPharma $ONCS OncoSec Medical
0 · Reply
highnihilism
highnihilism Sep. 24 at 1:14 PM
Market cap ≤ $500M (Unusual Volume, Health Care) $SSKN Strata Skin Sciences $ADVM Adverum Biotechnologies $GLTO Galecto
0 · Reply
StockScanners
StockScanners Sep. 24 at 1:47 AM
$ADVM reached 5.19, boom
0 · Reply
Mr_Magoo24
Mr_Magoo24 Sep. 23 at 7:38 PM
$ADVM so assuming they reach their PT its a 7.5X from here... not saying it will short term but that's a massive upside and in today's market it could 3X just from that analyst
0 · Reply
Stonkey
Stonkey Sep. 23 at 7:22 PM
$ADVM Ending the day red?
0 · Reply
MajorHuang
MajorHuang Sep. 23 at 6:52 PM
$ADVM NXXT rerate playbook clear grow ARR boost GM print wins showcase case studies then watch FOMO arrive 😎
0 · Reply
AlejandroGrant
AlejandroGrant Sep. 23 at 6:23 PM
$ADVM NXXT EPC contracts lined up would de risk execution and pull forward timelines Florida sun shining on this setup ☀️
0 · Reply
BiotechDrTrader
BiotechDrTrader Sep. 23 at 5:22 PM
$ADVM this company should not be $85M market cap, should at least be $300M+ with a great P3 asset in a massive market, ophthalmologists love them... this undervaluation is crazy
0 · Reply